Search Results - Yunlin Fu
- Showing 1 - 1 results of 1
-
1
First‐in‐human safety, tolerability, and pharmacokinetic results of DFV890, an oral low‐molecular‐weight NLRP3 inhibitor by Ewa Gatlik, Beata Mehes, Emilie Voltz, Ulrike Sommer, Elaine Tritto, Giulia Lestini, Xiaoxi Liu, Parasar Pal, Maria Velinova, Wiliam S. Denney, Yunlin Fu, Anthony Opipari, Dennis Dean, Guido Junge
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book